- Home
- IPST vs APLT Comparison
IPST vs APLT Comparison
Compare IPST & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPST
- APLT
- Stock Information
- Founded
- IPST 2011
- APLT 2016
- Country
- IPST United States
- APLT United States
- Employees
- IPST N/A
- APLT N/A
- Industry
- IPST Beverages (Production/Distribution)
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- IPST Consumer Staples
- APLT Health Care
- Exchange
- IPST Nasdaq
- APLT Nasdaq
- Market Cap
- IPST 163.4M
- APLT 178.6M
- IPO Year
- IPST 2024
- APLT 2019
- Fundamental
- Price
- IPST $0.63
- APLT $1.36
- Analyst Decision
- IPST
- APLT Buy
- Analyst Count
- IPST 0
- APLT 5
- Target Price
- IPST N/A
- APLT $4.13
- AVG Volume (30 Days)
- IPST 445.4K
- APLT 7.5M
- Earning Date
- IPST 11-25-2025
- APLT 11-10-2025
- Dividend Yield
- IPST N/A
- APLT N/A
- EPS Growth
- IPST N/A
- APLT N/A
- EPS
- IPST N/A
- APLT N/A
- Revenue
- IPST $7,058,550.00
- APLT $121,000.00
- Revenue This Year
- IPST N/A
- APLT N/A
- Revenue Next Year
- IPST N/A
- APLT $5,935.35
- P/E Ratio
- IPST N/A
- APLT N/A
- Revenue Growth
- IPST N/A
- APLT N/A
- 52 Week Low
- IPST $0.27
- APLT $0.30
- 52 Week High
- IPST $4.00
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- IPST N/A
- APLT 64.63
- Support Level
- IPST N/A
- APLT $1.21
- Resistance Level
- IPST N/A
- APLT $1.50
- Average True Range (ATR)
- IPST 0.00
- APLT 0.15
- MACD
- IPST 0.00
- APLT 0.01
- Stochastic Oscillator
- IPST 0.00
- APLT 70.81
About IPST Heritage Distilling Holding Company Inc. Common Stock
Heritage Distilling Holding Co Inc is a craft distiller producing, marketing, and selling a diverse line of award-winning craft spirits, including whiskeys, vodkas, gins, rums, and ready-to-drink canned cocktails. The company sells its products through wholesale distribution, directly to consumers through its owned and operated distilleries and tasting rooms located in Washington and Oregon, and by shipping directly to consumers online, where legal. Currently, it sells products in the Pacific Northwest with limited distribution in other states throughout the U.S.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.